Mulita, A.; Valsamaki, P.; Bekou, E.; Anevlavis, S.; Nanos, C.; Zisimopoulos, A.; Giatromanolaki, A.; Koukourakis, M.I.
Benefits from 18F-FDG PET-CT-Based Radiotherapy Planning in Stage III Non-Small-Cell Lung Cancer: A Prospective Single-Center Study. Cancers 2025, 17, 1969.
https://doi.org/10.3390/cancers17121969
AMA Style
Mulita A, Valsamaki P, Bekou E, Anevlavis S, Nanos C, Zisimopoulos A, Giatromanolaki A, Koukourakis MI.
Benefits from 18F-FDG PET-CT-Based Radiotherapy Planning in Stage III Non-Small-Cell Lung Cancer: A Prospective Single-Center Study. Cancers. 2025; 17(12):1969.
https://doi.org/10.3390/cancers17121969
Chicago/Turabian Style
Mulita, Admir, Pipitsa Valsamaki, Eleni Bekou, Stavros Anevlavis, Christos Nanos, Athanasios Zisimopoulos, Alexandra Giatromanolaki, and Michael I. Koukourakis.
2025. "Benefits from 18F-FDG PET-CT-Based Radiotherapy Planning in Stage III Non-Small-Cell Lung Cancer: A Prospective Single-Center Study" Cancers 17, no. 12: 1969.
https://doi.org/10.3390/cancers17121969
APA Style
Mulita, A., Valsamaki, P., Bekou, E., Anevlavis, S., Nanos, C., Zisimopoulos, A., Giatromanolaki, A., & Koukourakis, M. I.
(2025). Benefits from 18F-FDG PET-CT-Based Radiotherapy Planning in Stage III Non-Small-Cell Lung Cancer: A Prospective Single-Center Study. Cancers, 17(12), 1969.
https://doi.org/10.3390/cancers17121969